期刊文献+

孕中期血清唐氏综合征筛查与不良妊娠结局关联 被引量:8

Serum screening for Down's syndrome in the second trimester of pregnancy is associated with adverse pregnancy outcomes
下载PDF
导出
摘要 目的研究孕中期唐氏综合征筛查与不良妊娠结局关联及甲胎蛋白(AFP)、β人绒毛膜促性腺激素(β-HCG)、游离雌三醇(uE3)单个指标与不良妊娠发生的关联。方法采用连续性入组方法选取2014年3月31日至2021年4月29日在北京朝阳医院进行唐氏综合征筛查的孕妇进行回顾性队列研究。结果在7682例孕妇中,筛查高风险者492例,占6.40%;共有100例孕妇出现了不良妊娠结局(1.30%)。筛查高风险孕妇中有21例发生不良妊娠结局,发生率为4.27%,显著高于筛查低风险者(1.10%)。调整了糖尿病史、遗传病家族史、吸烟、饮酒后,与低风险值相比,筛查高风险者发生不良妊娠结局的可能性高达4.022倍(95%CI:2.405-6.442);21三体风险值越高,不良妊娠结局的发生率越高(P<0.001)。筛查高风险组在胎儿畸形、染色体异常、胎停育的发生率显著高于低风险组(P<0.05)。AFP原始数值每升高1 ng/mL,发生不良妊娠结局的可能性上升到1.019倍;AFP中位数倍数值(MOM)每升高1,发生不良妊娠结局的可能性上升2.258倍;uE3原始数值每升高1 ng/mL或uE3中位数倍数值每升高1,发生不良妊娠结局的可能性均可下降一半。结论孕中期唐氏综合征筛查高风险对胎儿畸形、染色体异常、胎停育等不良妊娠有提示作用;AFP高水平和uE3低水平可增加不良妊娠结局的发生。 Objective To explore the association between screening for Down's syndrome and adverse pregnancy outcomes.Methods Retrospective cohort study was conducted in Beijing Chaoyang Hospital covering pregnant 7682 pregnant women from Mar 31,2014 to Apr 29,2021 in a continuum period.Results The prevalence of high screening risk was 6.40%(492 cases)and the incidence of adverse pregnancy outcome was 1.30%(100 cases).The incidence of adverse outcome(4.27%)in high risk group was significantly higher than that in low risk group(1.10%).After adjusting for diabetes,family history of hereditary diseases,smoking and drinking alcohol,the incidence odds of adverse outcomes for high screening risk subjects was 4.022 times(95%CI:2.405-6.442)as that for low risk.The high Down's syndrome risk score meant high incidence of adverse outcomes(P<0.001).The incidences of malformations,chromosome abnormalities and stillbirth for high screening risk subjects were higherthan those for low risk.The incidence odds of adverse outcomes increased to 1.019 times with the increase of 1 ng/mL for AFP and 2.258 times with the increase of 1 for AFP MOM.The incidence odds of adverse outcomes declined to half with the increase of 1 ng/mL for uE3 or uE3 MOM.Conclusions Down's syndrome screening high risk is indicators for organ malformations,limb deformity,chromosome abnormalities and still birth.High level of AFP and low level of uE3 may increase the occurrence of adverse pregnancy outcomes.
作者 王战勇 徐静 梁燕 岳育红 WANG Zhan-yong;XU Jing;LIANG Yan;YUE Yu-hong(Department of Clinical Laboratory,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China)
出处 《基础医学与临床》 2022年第6期955-959,共5页 Basic and Clinical Medicine
关键词 孕中期血清唐氏综合征筛查 不良妊娠结局 AFP UE3 second trimester serum screening for Down's syndrome adverse pregnancy outcomes AFP uE3
  • 相关文献

参考文献7

二级参考文献51

  • 1Horacek J.Biochemical screening in the second trimester of pregnancy from a genetic aspect[J].Ceska Gynekol,1999,64:302-304.
  • 2Benn PA,Fang M,Egan JF.Trends in the use of second trimester maternal serum screening from 1991 to 2003[J].Genet Med,2005,7:328-331.
  • 3Perenc M,Dudarewicz L,Kaluzewski B.Utility of the triple test in the detection of abnormalities of the feto-placental unit[J].Med Sci Monit,2000,6:994-999.
  • 4Valerio D,Aiello R,Altieri V,et al.Maternal serum screening of fetal chromosomal abnormalities by AFP,UE3,hCG and free-beta hCG.Prospective and retrospective results[J].Minerva Ginecol,1996,48:169-173.
  • 5Merkatz IR,Nitowsky HM,Macri JN.An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities[J].Am J Obstet Gynecol,1984,148:886-894.
  • 6Phillips OP,Elias S,Shulman LP.Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein,hCG,and unconjugated estriol:a prospective 2-year study[J].Obstet Gynecol,1992,80:353-358.
  • 7Rosen DJ,Kedar I,Amiel A.A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%[J].Prenat Diagn,2002,22:59-63.
  • 8Liu SS,Lee FK,Lee JL,Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome[J].Acta Obstet Gynecol Scand,2004,83:1130 -1134.
  • 9Tul N,Pusenjak S,Osredkar J.Predicting complications of pregnancy with first-trimester maternal serum free-betahCG,PAPP-A and inhibin-A[J].Prenat Diagn,2003,23:990-996.
  • 10Ferriero DM.Neonatal brain injury[J].N Engl J Med,2004,351:1985-1995.

共引文献53

同被引文献82

引证文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部